
BEIJING: China's first artificial cornea product was licensed and released onto the market last year, according to China Food and Drug Administration (CFDA).
The artificial cornea has proved effective in treatment of corneal ulcers, said the CFDA in its report released Friday.
China holds intellectual property rights to the product's core technology, the administration said.
The Standard Group Plc is a multi-media organization with investments in media
platforms spanning newspaper print
operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a
leading multi-media house in Kenya with a key influence in matters of national
and international interest.